These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35849243)

  • 1. Epigenomics of conventional type-I dendritic cells depicted preferential control of TLR9 versus TLR3 response by NCoR1 through differential IRF3 activation.
    Mishra GP; Jha A; Ahad A; Sen K; Sen A; Podder S; Prusty S; Biswas VK; Gupta B; Raghav SK
    Cell Mol Life Sci; 2022 Jul; 79(8):429. PubMed ID: 35849243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCoR1 fine-tunes type-I IFN response in cDC1 dendritic cells by directly regulating Myd88-IRF7 axis under TLR9.
    Ahad A; Smita S; Mishra GP; Biswas VK; Sen K; Gupta B; Garcin D; Acha-Orbea H; Raghav SK
    Eur J Immunol; 2020 Dec; 50(12):1959-1975. PubMed ID: 32644192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMRT and NCoR1 fine-tune inflammatory versus tolerogenic balance in dendritic cells by differentially regulating STAT3 signaling.
    Jha A; Ahad A; Mishra GP; Sen K; Smita S; Minz AP; Biswas VK; Tripathy A; Senapati S; Gupta B; Acha-Orbea H; Raghav SK
    Front Immunol; 2022; 13():910705. PubMed ID: 36238311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
    Fujimoto K; Karuppuchamy T; Takemura N; Shimohigoshi M; Machida T; Haseda Y; Aoshi T; Ishii KJ; Akira S; Uematsu S
    J Immunol; 2011 Jun; 186(11):6287-95. PubMed ID: 21525388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NCoR1 controls immune tolerance in conventional dendritic cells by fine-tuning glycolysis and fatty acid oxidation.
    Sen K; Pati R; Jha A; Mishra GP; Prusty S; Chaudhary S; Swetalika S; Podder S; Sen A; Swain M; Nanda RK; Raghav SK
    Redox Biol; 2023 Feb; 59():102575. PubMed ID: 36565644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
    Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
    J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor agonist combinations augment mouse T-cell anti-tumor immunity via IL-12- and interferon ß-mediated suppression of immune checkpoint receptor expression.
    Jeon D; McNeel DG
    Oncoimmunology; 2022; 11(1):2054758. PubMed ID: 35340661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of EMT Factor ZEB1 in cDC1 "MutuDC Line" Mediated Induction of Th1 Immune Response.
    Smita S; Ahad A; Ghosh A; Biswas VK; Koga MM; Gupta B; Acha-Orbea H; Raghav SK
    Front Immunol; 2018; 9():2604. PubMed ID: 30483264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct dictation of Japanese encephalitis virus-induced neuroinflammation and lethality via triggering TLR3 and TLR4 signal pathways.
    Han YW; Choi JY; Uyangaa E; Kim SB; Kim JH; Kim BS; Kim K; Eo SK
    PLoS Pathog; 2014 Sep; 10(9):e1004319. PubMed ID: 25188232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular immune mechanisms of HPV-infected HaCaT cells in vitro based on toll-like receptors signaling pathway.
    Ying Z; Li X; Dang H; Yin N; Gao C
    J Clin Lab Anal; 2020 Mar; 34(3):e23101. PubMed ID: 31785031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma.
    Nojiri K; Sugimoto K; Shiraki K; Tameda M; Inagaki Y; Kusagawa S; Ogura S; Tanaka J; Yoneda M; Yamamoto N; Okano H; Takei Y; Ito M; Kasai C; Inoue H; Takase K
    Oncol Rep; 2013 May; 29(5):1737-43. PubMed ID: 23467704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hymenolepis diminuta: analysis of the expression of Toll-like receptor genes and protein (TLR3 and TLR9) in the small and large intestines of rats.
    Kosik-Bogacka DI; Wojtkowiak-Giera A; Kolasa A; Baranowska-Bosiacka I; Lanocha N; Wandurska-Nowak E; Izabela G; Salamatin R; Jagodzinski PP
    Exp Parasitol; 2014 Oct; 145():61-7. PubMed ID: 25092440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific.
    Wu J; Meng Z; Jiang M; Zhang E; Trippler M; Broering R; Bucchi A; Krux F; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
    Immunology; 2010 Mar; 129(3):363-74. PubMed ID: 19922426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Toll-like Receptor 3/9 Signaling Affects Properties and Impairs Glioma-Promoting Activity of Microglia.
    Huang Y; Zhang Q; Lubas M; Yuan Y; Yalcin F; Efe IE; Xia P; Motta E; Buonfiglioli A; Lehnardt S; Dzaye O; Flueh C; Synowitz M; Hu F; Kettenmann H
    J Neurosci; 2020 Aug; 40(33):6428-6443. PubMed ID: 32631940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Molecular Chaperone GRP78 Contributes to Toll-like Receptor 3-mediated Innate Immune Response to Hepatitis C Virus in Hepatocytes.
    Wei D; Li NL; Zeng Y; Liu B; Kumthip K; Wang TT; Huo D; Ingels JF; Lu L; Shang J; Li K
    J Biol Chem; 2016 Jun; 291(23):12294-309. PubMed ID: 27129228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma.
    Sheyhidin I; Nabi G; Hasim A; Zhang RP; Ainiwaer J; Ma H; Wang H
    World J Gastroenterol; 2011 Aug; 17(32):3745-51. PubMed ID: 21990957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.
    Sirén J; Pirhonen J; Julkunen I; Matikainen S
    J Immunol; 2005 Feb; 174(4):1932-7. PubMed ID: 15699120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR3-Mediated CD8+ Dendritic Cell Activation Is Coupled with Establishment of a Cell-Intrinsic Antiviral State.
    Széles L; Meissner F; Dunand-Sauthier I; Thelemann C; Hersch M; Singovski S; Haller S; Gobet F; Fuertes Marraco SA; Mann M; Garcin D; Acha-Orbea H; Reith W
    J Immunol; 2015 Aug; 195(3):1025-33. PubMed ID: 26101320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Plasmacytoid and Monocyte-Derived Dendritic Cells Display Distinct Metabolic Profile Upon RIG-I Activation.
    Fekete T; Sütö MI; Bencze D; Mázló A; Szabo A; Biro T; Bacsi A; Pazmandi K
    Front Immunol; 2018; 9():3070. PubMed ID: 30622542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor, Cognitive, and Behavioral Impairment in TLR3 and TLR9 Deficient Male Mice: Insights into the Non-Immunological Roles of Toll-Like Receptors.
    Vargas-Calderón H; Ortega-Robles E; Rocha L; Yu P; Arias-Carrión O
    Arch Med Res; 2024 Apr; 55(3):102985. PubMed ID: 38520880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.